Safety And Efficacy Of Perioperative Cisplatin/Gemcitabine (Cis/Gem) And Durvalumab (Durva) For Operable Muscle-Invasive Urothelial Carcinoma (Miuc): Sakk 06/17.

Richard Cathomas,Sacha Rothschild,Stefanie Hayoz,Martin Spahn,Julian Schardt,Roland Seiler,Andreas Erdmann,Stefanie Aeppli,Nicolas Mach,Raeto Strebel,Boris A. Hadaschik,Dominik R. Berthold,Miklos Pless,Deborah Zihler,Mathias Schmid,Martina Schneider,Zuzanna Maniecka,Ulf Petrausch

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 14|浏览29

暂无评分

摘要

430Background: The combination of cisplatin-based chemotherapy with immune checkpoint inhibitors is extensively investigated in urothelial carcinoma. Using this combination in the neoadjuvant setti...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要